|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-4-4
|
|
pubmed:abstractText |
Serum cystatin C (CysC) is a novel marker for kidney function that has been claimed to be superior to serum creatinine. Thyroid dysfunction may alter creatinine, which has been found to be increased in hypothyroidism and decreased in hyperthyroidism. This study was performed to evaluate whether changes in CysC and creatinine are parallel during the treatment of hypo- and hyperthyroidism, respectively.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0085-2538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1944-7
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12675875-Adolescent,
pubmed-meshheading:12675875-Adult,
pubmed-meshheading:12675875-Creatinine,
pubmed-meshheading:12675875-Cystatin C,
pubmed-meshheading:12675875-Cystatins,
pubmed-meshheading:12675875-Female,
pubmed-meshheading:12675875-Humans,
pubmed-meshheading:12675875-Hyperthyroidism,
pubmed-meshheading:12675875-Hypothyroidism,
pubmed-meshheading:12675875-Kidney,
pubmed-meshheading:12675875-Kidney Diseases,
pubmed-meshheading:12675875-Male,
pubmed-meshheading:12675875-Middle Aged
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Impact of thyroid dysfunction on serum cystatin C.
|
|
pubmed:affiliation |
Department of Internal Medicine, Division of Endocrinology and Diabetes, University Hospital of Zurich, Zurich, Switzerland.
|
|
pubmed:publicationType |
Journal Article
|
